Kyowa Kirin (4151.T)

Quick facts

Marketed products

• Poteligeo · Oncology · revenue 300
  Poteligeo works by binding to the C-C chemokine receptor type 4, which is involved in the migration and proliferation of T-cells.
• CRYSVITA · Other
• Nourianz · Neuroscience
  Nourianz works by blocking the adenosine receptor A2a, which helps to increase dopamine levels in the brain.
• Fareston · Oncology
  Fareston works by binding to estrogen receptors in the body, which can help reduce the growth of breast cancer cells.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Kyowa Kirin portfolio CI brief
• Kyowa Kirin pipeline updates RSS